The outlook revision acknowledges Doylestown’s marked rebound in liquidity and improved operating performance following unexpected losses during the first half of fiscal year 2016.
Moody’s also assigned a “Baa2” rating to Doylestown’s proposed $45 million of series 2016A bonds, $18.8 million of series 2016B bonds and $11.7 million of series 2016C bonds.
The rating assignment reflects Doylestown’s strong market position and proactive management team.
More articles on healthcare finance:
4 best practices for managing patient billing complaints
20 financial benchmarks for hospital executives
Quality Improvement Organizations resume two-midnight reviews
